cGMP and Cardiac Hypertrophy

BMC pharmacology & toxicology - United Kingdom
doi 10.1186/2050-6511-16-s1-a12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II

PLoS ONE
Multidisciplinary
2010English

Cardiac Mitochondrial cGMP Stimulates Cytochromecrelease

Clinical Science
Medicine
2006English

Mechanotransduction in Cardiac Hypertrophy and Failure

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2015English

Reciprocal Repression Between MicroRNA-133 and Calcineurin Regulates Cardiac Hypertrophy: A Novel Mechanism for Progressive Cardiac Hypertrophy

Hypertension
Internal Medicine
2010English

Partnering Up for Cardiac Hypertrophy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2006English

Cardiac Hypertrophy and the WNT/Frizzled Pathway

Hypertension
Internal Medicine
2007English

Non-Coding RNAs in Cardiac Hypertrophy

Journal of Physiology
PhysiologySports Science
2017English

Distinct Submembrane Localisation Compartmentalises Cardiac NPR1 and NPR2 Signalling to cGMP

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Cardiac Hypertrophy in Spontaneously Hypertensive Rats

Japanese Heart Journal
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy